Back to Search Start Over

E3 ubiquitin ligase RNF5 attenuates pathological cardiac hypertrophy through STING.

Authors :
Yang LL
Xiao WC
Li H
Hao ZY
Liu GZ
Zhang DH
Wu LM
Wang Z
Zhang YQ
Huang Z
Zhang YZ
Source :
Cell death & disease [Cell Death Dis] 2022 Oct 21; Vol. 13 (10), pp. 889. Date of Electronic Publication: 2022 Oct 21.
Publication Year :
2022

Abstract

Ring-finger protein 5 (RNF5) is an E3 ubiquitin ligase which is expressed in a variety of human tissues. RNF5 is involved in the regulation of endoplasmic reticulum stress, inflammation, and innate immunity and plays an important role in the occurrence and development of various tumors. However, the role of RNF5 in cardiac hypertrophy has not been reported. In this study, we found the expression of RNF5 was increased in the hearts of mice with pathological cardiac hypertrophy. The loss-of-function research demonstrated that RNF5 deficiency exacerbated cardiac hypertrophy, whereas gain-of-function studies revealed that overexpression of RNF5 had opposite effects. The stimulator of interferon genes (STING) is a signaling molecule that can activate type I interferon immunity, which can meditate inflammation and immune response in many diseases. The protein-protein interaction experiments confirmed that STING interacted with RNF5. Further studies showed that RNF5 inhibited cardiac hypertrophy by promoting STING degradation through K48-linked polyubiquitination. Therefore, we defined RNF5 as importantly regulated signaling for cardiac hypertrophy.<br /> (© 2022. The Author(s).)

Details

Language :
English
ISSN :
2041-4889
Volume :
13
Issue :
10
Database :
MEDLINE
Journal :
Cell death & disease
Publication Type :
Academic Journal
Accession number :
36270989
Full Text :
https://doi.org/10.1038/s41419-022-05231-8